Short-term exercise training improves aerobic capacity with no change in arterial function in obesity.

Tracy Baynard, R L Carhart, R S Weinstock, L L Ploutz-Snyder, J A Kanaley
Author Information
  1. Tracy Baynard: Exercise Science Department, Syracuse University, NY, 13244, USA. tbaynard@illinois.edu

Abstract

The aim of the study is to determine the effects of short-term high-intensity exercise on arterial function and glucose tolerance in obese individuals with and without the metabolic syndrome (MetSyn). Obese men and women (BMI > 30 kg/m(2); 39-60 years) with and without MetSyn (MetSyn, n = 13; Non-MetSyn, n = 13) participated in exercise training consisting of ten consecutive days of treadmill walking for 1 h/day at 70-75% of peak aerobic capacity. Changes in aerobic capacity, flow-mediated dilation (FMD), and arterial stiffness using central and peripheral pulse wave velocity (PWV) measurements were assessed pre- and post-training. These measurements were obtained fasting and 1-h post-test meal while the subjects were hyperglycemic. Aerobic capacity improved for both groups [Non-MetSyn 24.0 +/- 1.6 vs. 25.1 +/- 1.5 mL/(kg min); MetSyn 25.2 +/- 1.8 vs. 26.2 +/- 1.7 mL/(kg min), P < 0.05]. There was no change in body weight. FMD decreased by ~20% (P < 0.05) for both groups during acute hyperglycemia (MetSyn, n = 11; Non-MetSyn, n = 10), while hyperglycemia increased central PWV and not peripheral PWV. Exercise training did not change FMD in the fasted or challenged state. Central and peripheral PWV were not altered with training for either group (MetSyn, n = 13; Non-MetSyn, n = 13). A 10-day high-intensity exercise program in obese individuals improved aerobic capacity and glucose tolerance but no change in arterial function was observed. Acute hyperglycemia had a deleterious effect on arterial function, suggesting that persons with impaired glucose homeostasis may experience more opportunities for attenuated arterial function on a daily basis which could contribute to increased cardiovascular risk.

References

  1. Exp Diabetes Res. 2008;2008:672021 [PMID: 18350125]
  2. J Hum Hypertens. 2008 Oct;22(10):678-86 [PMID: 18432253]
  3. J Am Geriatr Soc. 1994 Apr;42(4):394-8 [PMID: 8144824]
  4. Am J Hypertens. 2004 Jun;17(6):540-3 [PMID: 15177529]
  5. Eur J Clin Invest. 1998 Apr;28(4):329-33 [PMID: 9615913]
  6. Diabetes. 1999 Sep;48(9):1856-62 [PMID: 10480619]
  7. J Am Coll Cardiol. 2001 Jun 1;37(7):1929-35 [PMID: 11401134]
  8. J Appl Physiol (1985). 2002 Aug;93(2):773-81 [PMID: 12133891]
  9. J Appl Physiol (1985). 2001 Mar;90(3):1102-10 [PMID: 11181626]
  10. Diabet Med. 2004 Jun;21(6):636-9 [PMID: 15154954]
  11. Am J Physiol. 1994 Feb;266(2 Pt 2):H693-701 [PMID: 8141370]
  12. Hypertension. 2008 Jul;52(1):72-9 [PMID: 18504322]
  13. Clin Exp Pharmacol Physiol. 2000 Apr;27(4):239-50 [PMID: 10779120]
  14. J Am Coll Cardiol. 2002 Jan 16;39(2):257-65 [PMID: 11788217]
  15. Diabetes Res Clin Pract. 2004 Aug;65(2):85-93 [PMID: 15223220]
  16. Circulation. 2003 Apr 29;107(16):2089-95 [PMID: 12695300]
  17. J Physiol. 2004 Nov 15;561(Pt 1):1-25 [PMID: 15375191]
  18. Hypertension. 1995 Sep;26(3):485-90 [PMID: 7649586]
  19. J Clin Invest. 1996 Jan 1;97(1):22-8 [PMID: 8550838]
  20. Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):406-10 [PMID: 15576637]
  21. Diabetes Care. 1988 Sep;11(8):613-8 [PMID: 3065001]
  22. J Appl Physiol (1985). 1997 May;82(5):1438-44 [PMID: 9134890]
  23. Clin Sci (Lond). 2004 Aug;107(2):191-6 [PMID: 15068394]
  24. Am J Physiol. 1992 Aug;263(2 Pt 2):H321-6 [PMID: 1510128]
  25. Am J Clin Nutr. 1996 Nov;64(5):685-93 [PMID: 8901786]
  26. J Appl Physiol (1985). 2003 Jan;94(1):234-44 [PMID: 12391095]
  27. Metabolism. 2005 Aug;54(8):989-94 [PMID: 16092046]
  28. JAMA. 2002 May 15;287(19):2570-81 [PMID: 12020339]
  29. Circulation. 2003 Aug 5;108(5):530-5 [PMID: 12874192]
  30. Circulation. 2002 Oct 15;106(16):2085-90 [PMID: 12379578]
  31. J Vasc Surg. 1998 Oct;28(4):687-94 [PMID: 9786265]
  32. Clin Sci (Lond). 2002 Jan;102(1):1-7 [PMID: 11749654]
  33. Can J Cardiol. 2002 Mar;18(3):259-62 [PMID: 11907614]
  34. Int J Clin Pract. 2007 Mar;61(3):397-402 [PMID: 17313605]
  35. Circ Res. 1994 Feb;74(2):349-53 [PMID: 7507417]
  36. Circulation. 2002 Sep 3;106(10):1211-8 [PMID: 12208795]
  37. J Am Coll Cardiol. 1999 Jul;34(1):146-54 [PMID: 10400004]
  38. Diabetes Care. 1998 Jul;21(7):1178-82 [PMID: 9653616]
  39. J Am Coll Cardiol. 2002 Aug 21;40(4):761-5 [PMID: 12204508]
  40. Atherosclerosis. 2001 Nov;159(1):35-41 [PMID: 11689204]
  41. Annu Rev Med. 1998;49:235-61 [PMID: 9509261]
  42. Diabet Med. 2006 May;23(5):469-80 [PMID: 16681555]
  43. Circulation. 1997 Jul 1;96(1):25-8 [PMID: 9236411]
  44. J Clin Endocrinol Metab. 2000 Jul;85(7):2402-10 [PMID: 10902785]
  45. J Am Coll Cardiol. 2000 Dec;36(7):2185-91 [PMID: 11127459]
  46. Circulation. 1998 May 5;97(17):1695-701 [PMID: 9591763]
  47. Circ Res. 1993 Nov;73(5):829-38 [PMID: 8403254]
  48. Diabetes Care. 2003 Jul;26(7):2119-25 [PMID: 12832323]
  49. Diabetes. 2003 Feb;52(2):448-52 [PMID: 12540620]
  50. Circulation. 2003 Feb 25;107(7):1017-23 [PMID: 12600916]

Grants

  1. R21 DK063179/NIDDK NIH HHS

MeSH Term

Adult
Arteries
Blood Flow Velocity
Blood Glucose
Body Composition
Body Mass Index
Body Weight
Energy Metabolism
Exercise
Exercise Test
Exercise Tolerance
Female
Humans
Insulin
Male
Metabolic Syndrome
Middle Aged
Obesity
Oxygen Consumption
Patient Selection
Vascular Resistance

Chemicals

Blood Glucose
Insulin

Word Cloud

Created with Highcharts 10.0.0arterialMetSynn=1functioncapacityexercise13trainingaerobicPWV+/-changeglucose2Non-MetSynFMDperipheral0hyperglycemiahigh-intensitytoleranceobeseindividualswithoutcentralmeasurementsimprovedgroupsvs25mL/kgminP<increasedaimstudydetermineeffectsshort-termmetabolicsyndromeObesemenwomenBMI>30kg/m39-60yearsparticipatedconsistingtenconsecutivedaystreadmillwalkingh/day70-75%peakChangesflow-mediateddilationstiffnessusingpulsewavevelocityassessedpre-post-trainingobtainedfasting1-hpost-testmealsubjectshyperglycemicAerobic[Non-MetSyn2465826705]bodyweightdecreased~20%05acute1110ExercisefastedchallengedstateCentralalteredeithergroup10-dayprogramobservedAcutedeleteriouseffectsuggestingpersonsimpairedhomeostasismayexperienceopportunitiesattenuateddailybasiscontributecardiovascularriskShort-termimprovesobesity

Similar Articles

Cited By